Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum

Malaria Journal

Volumn 12, Issue 1, 2013, Pages

  Flegg, Jennifer A ^a,b   Patil, Anand P ^a   Venkatesan, Meera ^c   Roper, Cally ^d   Naidoo, Inbarani ^e   Hay, Simon I ^a   Sibley, Carol Hopkins ^f   Guerin, Philippe J ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e Medical Research Council   (Saudi Arabia)

^f UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; DIHYDROPTEROATE SYNTHASE; PYRIMETHAMINE PLUS SULFADOXINE; SULFADOXINE;

ALLELE; ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CODON; GENE MUTATION; HUMAN; MALARIA FALCIPARUM; PLASMODIUM FALCIPARUM; SINGLE NUCLEOTIDE POLYMORPHISM; SPATIOTEMPORAL ANALYSIS;

AFRICA SOUTH OF THE SAHARA; ANTIMALARIALS; DIHYDROPTEROATE SYNTHASE; DRUG RESISTANCE; GEOGRAPHY; HUMANS; MODELS, THEORETICAL; MUTATION RATE; MUTATION, MISSENSE; PLASMODIUM FALCIPARUM; POLYMORPHISM, SINGLE NUCLEOTIDE; PREVALENCE; SULFADOXINE;

EID: 84880183895     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-12-249     Document Type: Article

References (30)

1. A new world malaria map: Plasmodium falciparum endemicity in 2010. Gething PW, Patil AP, Smith DL, Guerra CA, Elyazar IRF, Johnston GL, Tatem AJ, Hay SI, Malar J 2011 10 378 10.1186/1475-2875-10-378 22185615
2. Artemisinin resistance in Plasmodium falciparum malaria. Dondorp AM, Nosten F, Yi P, Das D, Phyo AP, Tarning J, Lwin KM, Ariey F, Hanpithakpong W, Lee SJ, Lee SJ, Ringwald P, Silamut K, Imwong M, Chotivanich K, Lim P, Herdman T, An SS, Yeung S, Singhasivanon P, Day NP, Lindegardh N, Socheat D, White NJ, N Engl J Med 2009 361 455 467 10.1056/NEJMoa0808859 19641202
3. Evidence of artemisinin-resistant malaria in western Cambodia. Noedl H, Se Y, Schaecher K, Smith BL, Socheat D, Fukuda MM, N Engl J Med 2008 359 2619 2620 10.1056/NEJMc0805011 19064625
4. Call to action: priorities for malaria elimination. Feachem RGA, Phillips AA, Targett GA, Snow RW, Lancet 2010 376 1517 1521 10.1016/S0140-6736(10)61500- 0 21035844
5. Drug-resistant malaria: changing patterns mean difficult decisions. Spencer HC, Trans R Soc Trop Med Hyg 1985 79 748 758 10.1016/0035-9203(85)90108- 7 3914115 (Pubitemid 16201807)
6. The dynamics of drug resistance in Plasmodium falciparum. Wernsdorfer W, Payne D, Pharmacol Ther 1991 50 95 121 10.1016/0163-7258(91)90074-V 1891480
7. Spread of chloroquine resistance in Plasmodium falciparum. Payne D, Parasitol Today 1987 3 241 246 10.1016/0169-4758(87)90147-5 15462966 (Pubitemid 17142151)
8. Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Sibley C, Hyde J, Sims P, Plowe C, Kublin J, Mberu E, Cowman A, Winstanley P, Watkins W, Nzila A, Trends Parasitol 2001 17 582 588 10.1016/S1471-4922(01) 02085-2 11756042 (Pubitemid 34088118)
9. Following the path of most resistance: dhpsK540E dispersal in African Plasmodium falciparum. Naidoo I, Roper C, Trends Parasitol 2010 26 447 456 10.1016/j.pt.2010.05.001 20728060
10. The de novo selection of drug resistant malaria parasites. White N, Pongtavornpinyo W, Proc R Soc Lond B Biol Sci 2003 270 545 554 10.1098/rspb.2002.2241 (Pubitemid 36308233)
11. Potential impact of host immunity on malaria treatment outcome in Tanzanian children infected with Plasmodium falciparum. Enevold A, Nkya W, Theisen M, Vestergaard L, Jensen A, Staalsoe T, Theander T, Bygbjerg I, Alifrangis M, Malar J 2007 6 153 10.1186/1475-2875-6-153 18021388
12. Decreasing efficacy of antimalarial combination therapy in Uganda is explained by decreasing host immunity rather than increasing drug resistance. Greenhouse B, Slater M, Njama-Meya D, Nzarubara B, Maiteki-Sebuguzi C, Clark TD, Staedke SG, Kamya MR, Hubbard A, Rosenthal PJ, Dorsey G, J Infect Dis 2009 199 758 765 10.1086/596741 19199542
13. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ, Antimicrob Agents Chemother 2005 49 3601 3606 10.1128/AAC.49.9.3601-3606.2005 16127028 (Pubitemid 41233006)
14. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated Plasmodium falciparum malaria. Dzinjalamala FK, Macheso A, Kublin JG, Taylor TE, Barnes KI, Molyneux ME, Plowe CV, Smith PJ, Am J Trop Med Hyg 2005 72 267 272 15772319 (Pubitemid 41278874)
15. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ, Malar J 2007 6 121 10.1186/1475-2875-6-121 17822535 (Pubitemid 47566322)
16. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria. Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G, Am J Trop Med Hyg 2003 69 247 251 14628939
17. Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. Kublin JG, Dzinjalamala FK, Kamwendo DD, Malkin EM, Cortese JF, Martino LM, Mukadam RAG, Rogerson SJ, Lescano AG, Molyneux ME, Winstanley PA, Chimpeni P, Taylor TE, Plowe CV, J Infect Dis 2002 185 380 388 10.1086/338566 11807721 (Pubitemid 34107252)
18. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria. Happi C, Gbotosho G, Folarin O, Akinboye D, Yusuf B, Ebong O, Sowunmi A, Kyle D, Milhous W, Wirth D, Oduala AM, Acta Trop 2005 95 183 193 10.1016/j.actatropica.2005.06.015 16023986 (Pubitemid 41207281)
19. Relationship between age, molecular markers, and response to sulphadoxine-pyrimethamine treatment in Kampala, Uganda. Staedke SG, Sendagire H, Lamola S, Kamya MR, Dorsey G, Rosenthal PJ, Trop Med Int Health 2004 9 624 629 10.1111/j.1365-3156.2004.01239.x 15117308 (Pubitemid 38657289)
20. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. Pearce RJ, Pota H, Evehe MSB, Ba EH, Mombo-Ngoma G, Malisa AL, Ord R, Inojosa W, Matondo A, Diallo DA, Mbacham W, van den Broek IV, Swarthout TD, Getachew A, Dejene S, Grobusch MP, Njie F, Dunyo S, Kweku M, Owusu-Agyei S, Chandramohan D, Bonnet M, Guthmann JP, Clarke S, Barnes KI, Streat E, Katokele ST, Uusiku P, Agboghoroma CO, Elegba OY, Cissé B, A-Elbasit IE, Giha HA, Kachur SP, Lynch C, Rwakimari JB, Chanda P, Hawela M, Sharp B, Naidoo I, Roper C, PLoS Med 2009 6 1000055 10.1371/journal.pmed.1000055 19365539
21. Allelic exchange at the endogenous genomic locus in Plasmodium falciparum proves the role of dihydropteroate synthase in sulfadoxine-resistant malaria. Triglia T, Wang P, Sims PFG, Hyde JE, Cowman AF, EMBO J 1998 17 3807 3815 10.1093/emboj/17.14.3807 9669998 (Pubitemid 28333967)
22. Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment. Harrington W, Mutabingwa T, Muehlenbachs A, Sorensen B, Bolla M, Fried M, Duffy P, Proc Natl Acad Sci 2009 106 9027 9032 10.1073/pnas.0901415106 19451638
23. High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at codon 581. Gesase S, Gosling RD, Hashim R, Ord R, Naidoo I, Madebe R, Mosha JF, Joho A, Mandia V, Mrema H, Mapunda E, Savael Z, Lemnge M, Mosha FW, Greenwood B, Roper C, Chandramohan D, PLoS One 2009 4 4569 10.1371/journal.pone.0004569 19238219
24. WHO, Policy recommendation on intermittent preventive treatment during infancy with sulfadoxine-pyrimethamine (SP-IPTi) for Plasmodium falciparum malaria control in Africa Geneva: World Health Organization 2010
25. Drug resistance maps to guide intermittent preventive treatment of malaria in African infants. Naidoo I, Roper C, Parasitology 2011 138 1469 1479 10.1017/S0031182011000746 21835078
26. WWARN Molecular Surveyor http://www.wwarn.org/surveyor/
27. Drug Resistance Maps http://www.drugresistancemaps.org
28. Anti-folate drug resistance in Africa: meta-analysis of reported dihydrofolate reductase(dhfr) and dihydropteroate synthase(dhps) mutant genotype frequencies in African Plasmodium falciparum parasite populations. Sridaran S, McClintock S, Syphard L, Herman K, Barnwell J, Udhayakumar V, Malar J 2010 9 247 10.1186/1475-2875-9-247 20799995
29. Temporal trends in monitoring antimalarial drug use in Africa. Flegg JA, Metcalf CJE, Gharbi M, Venkatesan M, Shewchuk T, Sibley CH, Guerin PJ, AmJTrop Med Hyg 2013 accepted (July 10 2013)
30. Population distribution, settlement patterns and accessibility across Africa in 2010. Linard C, Gilbert M, Snow RW, Noor AM, Tatem AJ, PLoS One 2012 7 31743 10.1371/journal.pone.0031743 22363717